Author: Pizzi Laura T.
Publisher: Adis International
ISSN: 1170-7690
Source: PharmacoEconomics, Vol.27, Iss.4, 2009-06, pp. : 329-339
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Transdermal Oxybutynin: For Overactive Bladder
By Bang L.M. Easthope S.E. Perry C.M.
Drugs & Aging, Vol. 20, Iss. 11, 2003-01 ,pp. :
Transdermal oxybutynin: a new treatment for overactive bladder
Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 12, 2003-12 ,pp. :
Oxybutynin gel for the treatment of overactive bladder
By Gomelsky Alex Dmochowski Roger R
Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 9, 2012-06 ,pp. :
Extended-release oxybutynin an effective option in overactive bladder
Inpharma, Vol. 1, Iss. 1303, 2001-01 ,pp. :
Oxybutynin ER vs tolterodine for overactive bladder
Inpharma, Vol. 1, Iss. 1291, 2001-01 ,pp. :